Javier Díez Selected Research

Javier Díez Research Topics

Disease

63	Heart Failure 06/2022 - 08/2002
63	Fibrosis (Cirrhosis) 06/2022 - 04/2002
35	Hypertension (High Blood Pressure) 11/2021 - 05/2003
21	Heart Diseases (Heart Disease) 01/2021 - 12/2002
16	Atherosclerosis 01/2021 - 01/2005
11	Hypertrophy 08/2012 - 03/2005
9	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 08/2012 - 01/2004
8	Inflammation (Inflammations) 11/2021 - 01/2005
8	Aortic Valve Stenosis (Aortic Stenosis) 04/2020 - 04/2014
8	Essential Hypertension 03/2014 - 01/2002
7	Chronic Renal Insufficiency 05/2022 - 12/2005
6	Left Ventricular Dysfunction 06/2022 - 04/2006
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 06/2004
5	Obesity 03/2018 - 01/2005
4	Pathologic Processes 11/2021 - 04/2005
4	Type 2 Diabetes Mellitus (MODY) 01/2021 - 05/2012
4	Atrial Fibrillation 01/2019 - 06/2006
4	Prediabetic State (Prediabetes) 03/2018 - 03/2013
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2015 - 01/2006
4	Insulin Resistance 12/2014 - 12/2008
3	Neoplasms (Cancer) 06/2022 - 01/2021
3	Systolic Heart Failure 10/2014 - 07/2006
2	Breast Neoplasms (Breast Cancer) 06/2022 - 12/2008
2	Ventricular Remodeling 01/2019 - 01/2018
2	Abdominal Obesity 03/2018 - 01/2015
2	Myocardial Infarction 11/2017 - 01/2014
2	Diastolic Heart Failure 10/2017 - 07/2006
2	Cardiomegaly (Heart Hypertrophy) 04/2015 - 10/2008
2	Kidney Diseases (Kidney Disease) 11/2013 - 12/2010
2	Necrosis 11/2012 - 05/2012
2	Ischemia 11/2012 - 02/2009
2	Body Weight (Weight, Body) 08/2010 - 09/2002

Drug/Important Bio-Agent (IBA)

49	Biomarkers (Surrogate Marker)IBA 06/2022 - 04/2002
40	CollagenIBA 01/2022 - 05/2002
19	NADPH Oxidases (NAD(P)H oxidase)IBA 04/2017 - 08/2004
16	Collagen Type I (Type I Collagen)IBA 01/2022 - 11/2003
15	Superoxides (Superoxide)IBA 04/2017 - 08/2004
13	Procollagen Type IIBA 01/2022 - 04/2002
11	CytokinesIBA 03/2014 - 03/2005
10	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2007
10	Angiotensin IIIBA 11/2017 - 01/2002
8	procollagen type I carboxy terminal peptide (PICP)IBA 06/2022 - 09/2007
7	Torsemide (Demadex)FDA LinkGeneric 01/2018 - 08/2002
6	Peptides (Polypeptides)IBA 11/2021 - 08/2005
6	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2021 - 03/2014
6	Antihypertensive Agents (Antihypertensives)IBA 08/2010 - 12/2002
5	Matrix Metalloproteinases (MMPs)IBA 01/2021 - 03/2004
5	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2021 - 05/2012
5	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 02/2020 - 03/2004
5	Furosemide (Lasix)FDA LinkGeneric 01/2018 - 08/2002
5	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 01/2017 - 02/2009
5	EnzymesIBA 01/2017 - 03/2004
5	Insulin (Novolin)FDA Link 12/2014 - 01/2006
5	Interleukin-6 (Interleukin 6)IBA 03/2014 - 11/2011
4	Spironolactone (Aldactone)FDA LinkGeneric 01/2022 - 01/2018
4	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 03/2013
4	SaltsIBA 01/2019 - 04/2006
4	Messenger RNA (mRNA)IBA 11/2017 - 10/2007
4	MicroRNAs (MicroRNA)IBA 01/2017 - 02/2009
4	Losartan (Cozaar)FDA LinkGeneric 01/2017 - 05/2002
4	NADP (NADPH)IBA 09/2010 - 11/2004
3	AldosteroneIBA 01/2021 - 01/2004
3	Collagen Type III (Type III Collagen)IBA 01/2021 - 03/2014
3	GadoliniumIBA 01/2021 - 08/2010
3	Troponin T (Troponin T1)IBA 01/2019 - 12/2016
3	HDL CholesterolIBA 03/2018 - 01/2015
3	Natriuretic PeptidesIBA 01/2017 - 02/2009
3	Tissue Inhibitor of Metalloproteinase-1IBA 01/2016 - 06/2010
3	Fibrillar CollagensIBA 08/2015 - 12/2002
3	cardiotrophin 1IBA 03/2014 - 08/2012
3	CalciumIBA 11/2012 - 05/2012
3	LeptinIBA 09/2010 - 09/2002
3	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 08/2009 - 06/2004
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 05/2008 - 12/2002
3	4- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA 02/2008 - 05/2003
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2007 - 11/2004
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2007 - 07/2005
2	Galectin 3 (LGALS3)IBA 01/2021 - 04/2015
2	procollagen Type III-N-terminal peptide (PIIP)IBA 01/2021 - 04/2015
2	Biological ProductsIBA 01/2018 - 12/2008
2	CreatinineIBA 09/2017 - 03/2009
2	Triglycerides (Triacylglycerol)IBA 04/2017 - 11/2015
2	2- butyl- 4- chloro- 1- ((2'- (1H- tetrazol- 5- yl)(1,1'- biphenyl)- 4- yl)methyl)- 1H- imidazole- 5- carboxaldehydeIBA 01/2017 - 10/2009
2	Connective Tissue Growth FactorIBA 01/2017 - 11/2013
2	pro-brain natriuretic peptide (1-76)IBA 12/2016 - 02/2009
2	OsteopontinIBA 01/2016 - 07/2013
2	Uric Acid (Urate)IBA 11/2015 - 06/2006
2	G-Protein-Coupled Receptor Kinase 2IBA 12/2014 - 10/2010
2	Mitochondrial Permeability Transition PoreIBA 11/2012 - 05/2012
2	Waste Products (Waste Product)IBA 11/2012 - 05/2012
2	Free RadicalsIBA 11/2012 - 05/2012
2	Oxygen (Dioxygen)IBA 11/2012 - 05/2012
2	Annexin A5IBA 11/2011 - 11/2007
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 05/2011 - 03/2006
2	C-Reactive ProteinIBA 12/2010 - 04/2006
2	Oxidoreductases (Dehydrogenase)IBA 07/2009 - 12/2005

Therapy/Procedure

12	Therapeutics 05/2022 - 02/2009
2	Drug Therapy (Chemotherapy) 06/2022 - 01/2021
2	Precision Medicine 03/2020 - 01/2018
2	Cardiac Resynchronization Therapy 11/2010 - 06/2006